Acute olanzapine overdose in a toddler: A case report

Therapeutic Drug Monitoring

Volumn 35, Issue 5, 2013, Pages 557-559

  Tanoshima, Reo ^a   Chandranipapongse, Weerawadee ^a   Colantonio, David ^a   Stefan, Cristiana ^b   Nulman, Irena ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

child; olanzapine; overdose; pharmacokinetics; prolactin

Indexed keywords

ACTIVATED CARBON; OLANZAPINE; PROLACTIN;

AGITATION; ARTICLE; CASE REPORT; CHILD; CHILDHOOD INJURY; DROWSINESS; DRUG HALF LIFE; DRUG INTOXICATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LETHARGY; LIQUID CHROMATOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; TANDEM MASS SPECTROMETRY;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DRUG OVERDOSE; FEMALE; HALF-LIFE; HUMANS; INFANT; PROLACTIN;

EID: 84885023108     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182953ed8     Document Type: Article

References (16)

1. MacDonald GJ, Bartolomé JM. A decade of progress in the discovery and development of "atypical" antipsychotics. Prog Med Chem. 2010;49:37-80
2. DuBois D. Toxicology and overdose of atypical antipsychotic medications in children: Does newer necessarily mean safer? Curr Opin Pediatr. 2005;17:227
3. Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164:870-876
4. Bonin MM, Burkhart KK. Olanzapine overdose in a 1-year-old male. Pediatr Emerg Care. 1999;15:266-267
5. Catalano G, Cooper DS, Catakano MC, et al. Olanzapine overdose in an 18-month-old child. J Child Adolesc Psychopharmacol. 1999;9:267-271
6. Yip L, Dart RC, Graham K. Olanzapine toxicity in a toddler. Pediatrics. 1998;102:1494
7. Lankheet NAG, Padberg RD, De Kluiver EM, et al. Relatively mild symptoms after an olanzapine intoxication in a 2-year-old girl with excessively high serum levels. J Child Adolesc Psychopharmacol. 2011;21:93-95
8. Theisen FM, Grabarkiewicz J, Fegbeutel C, et al. Olanzapine overdose in children and adolescents: Two case reports and a review of the literature. J Child Adolesc Psychopharmacol. 2005;15:986-995
9. Oesterheld Jr. A review of developmental aspects of cytochrome P450. J Child Adolesc Psychopharmacol. 1998;8:161-174
10. Zyprexia [package insert]. Indianapolis, IN: Eli Lilly and Company; 2011
11. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157-1167
12. Grothe DR, Calis KA, Jacobsen L, et al. Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia. J Clin Psychopharmacol. 2000;20:220-225
13. Brunton L, Chabner B, Knollman B. Goodman and Giilman's the Pharmacological Basis of Therapeutics. 12th ed. San Francisco, CA: McGraw-Hill Professional Publishing; 2010
14. Skogh E, Sjodn I, Josefsson M, et al. High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medication with oral olanzapine as the only antipsychotic drug. J Clin Psychopharmacol. 2011;31:4-9
15. Greenspan SF, Gardner GD. Basic & Clinical Endocrinology. 6th ed. San Francisco, CA: McGraw-Hill Professional Publishing; 2001
16. Masi G, Cosenza A, Mucci M. Prolactin levels in young children with pervasive developmental disorders during risperidone treatment. J Child Adolesc Psychopharmacol. 2001;11:389-394